Literature DB >> 27297501

Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia.

Wuyan Chen1, Ashley F Perritt2, Rachel Morissette2, Jennifer L Dreiling3, Markus-Frederik Bohn4, Ashwini Mallappa2, Zhi Xu5, Martha Quezado3, Deborah P Merke2,6.   

Abstract

Some variants that cause autosomal-recessive congenital adrenal hyperplasia (CAH) also cause hypermobility type Ehlers-Danlos syndrome (EDS) due to the monoallelic presence of a chimera disrupting two flanking genes: CYP21A2, encoding 21-hydroxylase, necessary for cortisol and aldosterone biosynthesis, and TNXB, encoding tenascin-X, an extracellular matrix protein. Two types of CAH tenascin-X (CAH-X) chimeras have been described with a total deletion of CYP21A2 and characteristic TNXB variants. CAH-X CH-1 has a TNXB exon 35 120-bp deletion resulting in haploinsufficiency, and CAH-X CH-2 has a TNXB exon 40 c.12174C>G (p.Cys4058Trp) variant resulting in a dominant-negative effect. We present here three patients with biallelic CAH-X and identify a novel dominant-negative chimera termed CAH-X CH-3. Compared with monoallelic CAH-X, biallelic CAH-X results in a more severe phenotype with skin features characteristic of classical EDS. We present evidence for disrupted tenascin-X function and computational data linking the type of TNXB variant to disease severity.
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  CAH-X; Ehlers-Danlos syndrome; biallelic; congenital adrenal hyperplasia; tenascin-X

Mesh:

Substances:

Year:  2016        PMID: 27297501      PMCID: PMC4983206          DOI: 10.1002/humu.23028

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  A hierarchical approach to all-atom protein loop prediction.

Authors:  Matthew P Jacobson; David L Pincus; Chaya S Rapp; Tyler J F Day; Barry Honig; David E Shaw; Richard A Friesner
Journal:  Proteins       Date:  2004-05-01

2.  A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.

Authors:  J Schalkwijk; M C Zweers; P M Steijlen; W B Dean; G Taylor; I M van Vlijmen; B van Haren; W L Miller; J Bristow
Journal:  N Engl J Med       Date:  2001-10-18       Impact factor: 91.245

3.  Ehlers-Danlos syndrome - a commonly misunderstood group of conditions.

Authors:  Glenda Sobey
Journal:  Clin Med (Lond)       Date:  2014-08       Impact factor: 2.659

4.  Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia.

Authors:  Rachel Morissette; Wuyan Chen; Ashley F Perritt; Jennifer L Dreiling; Andrew E Arai; Vandana Sachdev; Hwaida Hannoush; Ashwini Mallappa; Zhi Xu; Nazli B McDonnell; Martha Quezado; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2015-06-15       Impact factor: 5.958

Review 5.  The Ehlers-Danlos syndrome, a disorder with many faces.

Authors:  A De Paepe; F Malfait
Journal:  Clin Genet       Date:  2012-03-15       Impact factor: 4.438

6.  Structure-based approach to the prediction of disulfide bonds in proteins.

Authors:  Noeris K Salam; Matvey Adzhigirey; Woody Sherman; David A Pearlman
Journal:  Protein Eng Des Sel       Date:  2014-05-08       Impact factor: 1.650

7.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

8.  Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.

Authors:  David Egging; Ivonne van Vlijmen-Willems; Tomas van Tongeren; Joost Schalkwijk; Anita Peeters
Journal:  Connect Tissue Res       Date:  2007       Impact factor: 3.417

9.  Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Wuyan Chen; Rachel Morissette; Zhi Xu; Carol Van Ryzin; Vandana Sachdev; Hwaida Hannoush; Sujata M Shanbhag; Ana T Acevedo; Miki Nishitani; Andrew E Arai; Nazli B McDonnell
Journal:  J Clin Endocrinol Metab       Date:  2013-01-02       Impact factor: 5.958

Review 10.  Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players.

Authors:  Nazneen Rahman; Richard H Scott
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

View more
  15 in total

Review 1.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

2.  High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.

Authors:  Qizong Lao; Brittany Brookner; Deborah P Merke
Journal:  J Mol Diagn       Date:  2019-06-21       Impact factor: 5.568

3.  Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.

Authors:  Lucia Micale; Carmela Fusco; Marco Castori
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.

Authors:  Rosa Maria Paragliola; Alessia Perrucci; Laura Foca; Andrea Urbani; Paola Concolino
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

5.  Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.

Authors:  Pavlos Fanis; Nicos Skordis; Leonidas A Phylactou; Vassos Neocleous
Journal:  Hormones (Athens)       Date:  2022-10-20       Impact factor: 3.419

6.  Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice.

Authors:  Marie-Eve Bergeron; Anguel Stefanov; Christina K Haston
Journal:  Mamm Genome       Date:  2018-09-01       Impact factor: 2.957

Review 7.  46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.

Authors:  Federico Baronio; Rita Ortolano; Soara Menabò; Alessandra Cassio; Lilia Baldazzi; Valeria Di Natale; Giacomo Tonti; Benedetta Vestrucci; Antonio Balsamo
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

8.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

Authors:  Daisy Rymen; Marco Ritelli; Nicoletta Zoppi; Valeria Cinquina; Cecilia Giunta; Marianne Rohrbach; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

Review 9.  Genetics of congenital adrenal hyperplasia.

Authors:  Nils Krone; Wiebke Arlt
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690

Review 10.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.